Key facts
- This page summarizes Vijay Yabannavar's Form 4 filing for Gritstone bio, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Nov 2021, 16:57.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Footnote F2
Includes 3,696 shares of common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c) and 28,000 RSUs which vest over time measured from the grant date.
SEC remarks
Executive Vice President, Manufacturing and Tech Ops